Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COM Direxion Auspice Broad Commodity Strategy ETF	$29.37 +0.1%	$28.39	$27.56 ▼ $31.62	$261.39M	0.19	42,231 shs	8,784 shs
PNEXF Pharnext	$400.00	$400,360.00	$0.00 ▼ $0.00	N/A	N/A	433 shs	16,660 shs
PREV PreveCeutical Medical		$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	694,224 shs
TNGN Tengion		$0.00	$0.00 ▼ $0.00	N/A	N/A	6,051 shs	10,000 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COM Direxion Auspice Broad Commodity Strategy ETF	-0.58%	-0.03%	+2.30%	+5.85%	-6.08%
PNEXF Pharnext	0.00%	0.00%	0.00%	-99.99%	-100.00%
PREV PreveCeutical Medical	0.00%	0.00%	0.00%	0.00%	0.00%

[Urgent!] Generational Wealth Gameplan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PNEXF Pharnext	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COM Direxion Auspice Broad Commodity Strategy ETF	0.00	N/A	N/A	N/A
PNEXF Pharnext	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	N/A	N/A	N/A	N/A	N/A
PNEXF Pharnext	N/A	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	N/A	∞	N/A	N/A	N/A	N/A	N/A
PNEXF Pharnext	N/A	N/A	∞	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COM Direxion Auspice Broad Commodity Strategy ETF	$2.53	8.61%	N/A	N/A	N/A
PNEXF Pharnext	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
COM Direxion Auspice Broad Commodity Strategy ETF	N/A
PNEXF Pharnext	N/A
PREV PreveCeutical Medical	N/A
TNGN Tengion	N/A

Insider Ownership

Company	Insider Ownership
COM Direxion Auspice Broad Commodity Strategy ETF	N/A
PNEXF Pharnext	N/A
PREV PreveCeutical Medical	N/A
TNGN Tengion	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
COM Direxion Auspice Broad Commodity Strategy ETF	N/A	8.90 million	N/A	Not Optionable
PNEXF Pharnext	23	N/A	N/A	Not Optionable
PREV PreveCeutical Medical	N/A	N/A	N/A	Not Optionable
TNGN Tengion	147,000	N/A	N/A	Not Optionable

PNEXF, PREV, TNGN, and COM Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Green Gold Rush: Here's What's Driving Cannabis Stocks Higher
April 2, 2024 7:17 AM
View Green Gold Rush: Here's What's Driving Cannabis Stocks Higher
What is the Nasdaq? Complete Overview with History
April 16, 2024 8:00 AM
View What is the Nasdaq? Complete Overview with History

All Headlines

Company Descriptions

Direxion Auspice Broad Commodity Strategy ETF

NYSEARCA:COM

The Direxion Auspice Broad Commodity Strategy ETF (COM) is an exchange-traded fund that is based on the Auspice Broad Commodity index. The fund tracks a broad-market index consisting of 12 commodity futures contracts, weighted by historical volatility, which can toggle to cash based on momentum. The fund will also hold short-term fixed income securities as collateral. COM was launched on Mar 30, 2017 and is managed by Direxion.

Pharnext

OTCMKTS:PNEXF

Pharnext SA, a clinical-stage biopharmaceutical company, engages in the development of therapies for neurodegenerative diseases with high unmet medical needs. Its products include PXT3003, a novel fixed-dose synergistic combination of baclofen, naltrexone, and sorbitol formulated that is in Phase III clinical trials for the treatment of Charcot-Marie-tooth disease type 1A; and PXT864 to treat amyotrophic lateral sclerosis. The company was incorporated in 2007 and is headquartered in Paris, France.

PreveCeutical Medical

CNSX:PREV

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Tengion

OTCMKTS:TNGN

Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial